Splose raises AUD$46 million (~US$32.6 million) in Series A funding to build and deploy its specialized AI-powered practice management software for Allied Health professionals.
According to the official funding announcement, US-based growth equity firm Spectrum Equity led the investment round with participation from Athletic Ventures, and EVP (Equity Venture Partners), a Sydney-based venture capital firm that invests in early-stage B2B SaaS companies.
Splose has raised approximately AUD$51 million (~US$36.2 million) in funding to date, according to the latest funding data compiled by Digital Health Funding. The startup previously secured AUD$5 million (~US$3.5 million) in seed funding in February 2025.
Founded in 2018 by Nicholas Sanderson, Splose started with a simple goal: Practitioners were spending more time on admin tasks than with patients. All the time that should have gone to care was wasted on manually moving data between different software, navigating clunky patient booking portals, trying to manage payments, and hours of manual reconciliation just to understand where their business was. Splose solves these problems by offering an all-in-one digital practice management platform.
According to the data provided by Splose, its platform is currently serving over 20,000 Allied Health professionals across Australia, the UK, and New Zealand.
With the latest funds, Splose plans to deepen its market footprint in Australia and further expand into the UK healthcare market in 2026.
Digital health companies have secured more than $170 billion in venture capital funding to date, according to the latest funding data compiled by Digital Health Funding. More recently, Synthpop, a healthcare artificial intelligence company focused on automating administrative workflows for providers and insurers, raised $15 million in a Series A funding round, bringing its total funding to $23 million to date.